Engimmune Therapeutics

Engimmune Therapeutics is a platform and product development company that uses cutting-edge technology to design highly efficient and specific T-cell receptor (TCR) therapies. By applying a proprietary platform technology that integrates genomic editing, functional high-throughput screening, deep sequencing, and machine learning, Engimmune addresses the key efficacy and safety challenges currently limiting the full potential of TCR-T cell and soluble TCR therapies. Engimmune’s lead products are focused on oncology, with the potential to expand into autoimmune diseases in the future.